Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques.
Verhagen OJ, Wijkhuijs AJ, van der Sluijs-Gelling AJ, Szczepański T, van der Linden-Schrever BE, Pongers-Willemse MJ, van Wering ER, van Dongen JJ, van der Schoot CE. Verhagen OJ, et al. Among authors: van der linden schrever be, van dongen jj, van der schoot ce, van der sluijs gelling aj, van wering er. Leukemia. 1999 Aug;13(8):1298-9. doi: 10.1038/sj.leu.2401451. Leukemia. 1999. PMID: 10450765 No abstract available.
Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.
Szczepański T, Beishuizen A, Pongers-Willemse MJ, Hählen K, Van Wering ER, Wijkhuijs AJ, Tibbe GJ, De Bruijn MA, Van Dongen JJ. Szczepański T, et al. Among authors: van dongen jj, van wering er. Leukemia. 1999 Feb;13(2):196-205. doi: 10.1038/sj.leu.2401277. Leukemia. 1999. PMID: 10025893 Clinical Trial.
T-lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies.
van Wering ER, van der Linden-Schrever BE, van der Velden VH, Szczepański T, van Dongen JJ. van Wering ER, et al. Among authors: van der velden vh, van der linden schrever be, van dongen jj. Leukemia. 2001 Aug;15(8):1301-3. doi: 10.1038/sj.leu.2402184. Leukemia. 2001. PMID: 11480575 No abstract available.
Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.
van der Velden VH, Willemse MJ, van der Schoot CE, Hählen K, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj, van der schoot ce, van wering er. Leukemia. 2002 May;16(5):928-36. doi: 10.1038/sj.leu.2402475. Leukemia. 2002. PMID: 11986956
Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease.
Beishuizen A, de Bruijn MA, Pongers-Willemse MJ, Verhoeven MA, van Wering ER, Hählen K, Breit TM, de Bruin-Versteeg S, Hooijkaas H, van Dongen JJ. Beishuizen A, et al. Among authors: van dongen jj, van wering er. Leukemia. 1997 Dec;11(12):2200-7. doi: 10.1038/sj.leu.2400904. Leukemia. 1997. PMID: 9447841
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
Lúcio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E, Porwit-MacDonald A, Bjorklund E, Gaipa G, Biondi A, Orfao A, Janossy G, van Dongen JJ, San Miguel JF. Lúcio P, et al. Among authors: van dongen jj, van den beemd mw, van wering er, van lochem eg. Leukemia. 1999 Mar;13(3):419-27. doi: 10.1038/sj.leu.2401279. Leukemia. 1999. PMID: 10086733
Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia.
van der Velden VH, Joosten SA, Willemse MJ, van Wering ER, Lankester AW, van Dongen JJ, Hoogerbrugge PM. van der Velden VH, et al. Among authors: van dongen jj, van wering er. Leukemia. 2001 Sep;15(9):1485-7. doi: 10.1038/sj.leu.2402198. Leukemia. 2001. PMID: 11516112 No abstract available.
182 results